Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02990377 · ClinicalTrials.gov registry record · NA

Reducing Non-Medical Opioid Use: An Automatically Adaptive mHealth Intervention

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
459
Enrollment target

NCT02990377 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 459 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02990377, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
459 participants
Enrollment target

Study Summary

In recent years in the U.S., problems associated with opioid prescriptions, including non-medical use and overdose, increased to historically unprecedented levels and represent a public health crisis. Emergency departments (EDs) play an important role in opioid prescribing, particularly to individuals at high risk for adverse opioid-related outcomes. The purpose of this study is to determine whether a new mobile health (mhealth) intervention can assist people in the safe use of opioid analgesic (OA) medications after leaving the emergency department (ED). The specific aims of this project are to: (1) adapt and enhance an existing motivational intervention to decrease non-medical opioid use after an ED visit by optimizing intervention intensity and duration through reinforcement learning (RL); (2) examine the impact of an RL-supported intervention on non-medical opioid use level during the six months post-ED visit; and (3) examine the impact of the RL intervention on the opioid-related behaviors and adverse outcomes of driving after opioid use, overdose risk behaviors, and subsequent opioid-related ED visits. The secondary aims of this project are to: (SA1) examine whether baseline level of non-medical opioid use moderates the effects of the intervention; and (SA2) understand barriers and facilitators of implementation of the intervention based on qualitative interviews with ED patients.

Interventions

  • BEHAVIORAL RL-supported IVR intervention

Trial Details

FieldValue
Enrollment Target 459 participants
Start Date 2018-11-06
Est. Completion 2021-12-31
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02990377

The ClinicalTrials.gov registry entry for NCT02990377 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 459 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which RL-supported IVR intervention is the first listed.

NCT02990377 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02990377 about?

NCT02990377 is a clinical study titled "Reducing Non-Medical Opioid Use: An Automatically Adaptive mHealth Intervention". In recent years in the U.S., problems associated with opioid prescriptions, including non-medical use and overdose, increased to historically unprecedented levels and represent a public health crisis. Emergency departments (EDs) play an important role in opioid prescribing, particularly to individua...

What is the current status of trial NCT02990377?

This trial is currently completed. It is a NA study. The enrollment target is 459 participants. The study started on 2018-11-06. Estimated completion is 2021-12-31.

What interventions are being tested in trial NCT02990377?

The interventions under investigation include: RL-supported IVR intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02990377?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.